Spectral MD - 1H22 Results Update - Sep 2022
Following an exciting update from SMD, which confirmed that the FY23 commercialisation of the DFU Application in the US remains on track: a significant milestone and would represent the company's first non-R&D-linked revenue stream. Solid progress was made across the Burns, DFU, and Handheld Applications in 1H22, with SMD hitting several key operating milestones, winning further BARDA funding (which, we believe, also signals an increasing probability of federal procurement contracts in future), and delivering 76% revenue (linked to R&D activity) growth vs. 1H21.
Capital Access Group advises companies on effective engagement with investors. Our experienced team offers market-leading access with hard-to-reach investors, including smaller institutions, pension funds and private client fund managers. These under-serviced investors are located not only in London but across the regions of the UK and Europe. We have an unrivalled knowledge of this extensive audience, to whom our published research is distributed, as well as to larger institutions. We offer this service as part of an integrated investor communications strategy to promote a company’s investment story.
Our clients, ranging from AIM to FTSE 100 companies, benefit from our professional, long-term relationships with investors. Not only do we identify and target investors, we contact them directly and relay their views back to clients with analysis, interpretation and advice. This ensures that our clients are in control of their investor engagement. The objective is to improve the reach and engagement with investors, which in turn strengthens the share price.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.